CLEVELAND, Ohio — Patients with Type 1 diabetes have lost the specialized pancreatic cells that produce insulin, putting them ...
An “immune system reset” eliminated autoimmune, or Type 1, diabetes in mice in a study conducted at. Researchers say the strategy could also have potential for treating other autoimmune diseases and ...
Researchers at UChicago have developed a nanoparticle system that can effectively deliver mRNA to insulin-producing cells, protecting them from the body’s autoimmune response ...
When the pancreas stops producing insulin, glucose doesn't enter our cells. Instead, it accumulates in the bloodstream. In ...
Diabetes is a chronic health condition that impairs the body's ability to use or produce insulin, a hormone that regulates the conversion of sugar from food into energy, resulting in dangerously ...
Type 1 diabetes has shifted from a condition once associated with early mortality to a chronic disease owing to the development of intensive insulin therapy, continuous glucose monitoring, and hybrid ...
A type 1 diabetic dad is 1.8 times more likely to pass the condition on to his kids than a type 1 diabetic mom, who, research suggests, confers long-term protection against it. The findings open the ...
Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...
While it has long been known that type 1 diabetes runs in families, experts are less certain about what actually starts the autoimmune attack that defines the disease. Most people with type 1 diabetes ...
A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use an automated insulin delivery system. It’s hoped that this will lead to the ...
When someone is diagnosed with diabetes, it’s usually pretty simple which one they have — Type 1 or Type 2. The rate of diabetes has grown worldwide, having surpassed 800 million people a year ago. By ...